Skip to main content

Table 1 Correlations between expression of TRIM47 protein and clinicopathological factors

From: TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4

Clinicopathological feature

Total

100

Expression of TRIM47

P value

(χ2 test)

Low

(n = 24,24%)

High

(n = 76,76%)

Age(years)

 < 65

48

10(41.7)

38(50.0)

0.476

 ≥65

52

14(58.3)

38(50.0)

Gender

 Male

67

18(75.0)

49(64.5)

0.339

 Female

33

6(25.0)

27(35.5)

Tumor location

 Rectum

47

11(45.8)

36(47.4)

0.895

 Colon

53

13(54.2)

40(52.6)

Tumor size

 <30cm3

68

21(87.5)

47(61.8)

0.019

 ≥30 cm3

32

3(12.5)

29(38.2)

Histological differentiation

 Well/moderate

23

10(41.7)

13(17.1)

0.013

 Poor

77

14(58.3)

63(82.9)

T classification

 T1,2

21

9(37.5)

12(15.8)

0.023

 T3,4

79

15(62.5)

64(84.2)

TNM stage(AJCC)

 Stage I, II

43

6(25.0)

37(48.7)

0.041

 Stage III, IV

57

18(75.0)

39(51.3)

Invasive depth

 Mucous/muscular layer

20

8(33.3)

12(15.8)

0.080

 Serosa

80

16(66.7)

64(84.2)

Lymph node metastasis

 Absent

57

18(75.0)

39(51.3)

0.041

 Present

43

6(25.0)

37(48.7)

Distant metastasis

 Absent

86

22(91.7)

64(84.2)

0.508

 Present

14

2(8.3)

12(15.8)

Vascular invasion

 Absent

69

19(79.2)

50(65.8)

0.217

 Present

31

5(20.8)

26(34.2)